Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer

PURPOSE: We retrospectively determined the efficacy and safety of the combination of oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) as first-line chemotherapy for patients with metastatic or recurrent gastric cancer. MATERIALS AND METHODS: Between January 2006 and August 2009, 39 patients...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kim, Han Jo, Eun, Jun Young, Jeon, Young Woo, Yun, Jina, Kim, Kyoung Ha, Kim, Se Hyung, Kim, Hyun Jung, Lee, Sang-Cheol, Bae, Sang Byung, Kim, Chan Kyu, Lee, Nam Su, Lee, Kyu Taek, Park, Seong-Kyu, Won, Jong-Ho, Hong, Dae Sik, Park, Hee Sook
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Cancer Association 2011
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3192876/
https://ncbi.nlm.nih.gov/pubmed/22022292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2011.43.3.154
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge